Americans Are Dangerously Dependent on Foreign-made Generic Drugs. Tariffs Can Fix That.
Tariffs on pharmaceutical companies isn’t just good economic policy — it benefits national security and public health.
CPA Supports Senator Rick Scott’s Legislative Package to Protect American Investors from Chinese Exploitation
This legislative initiative aligns with CPA’s commitment to ensuring that U.S. capital does not inadvertently support adversarial regimes that undermine America’s economic and national security interests.
CPA Responds to Chinese Government Sanctions: “We Won’t Be Deterred”
CPA remains unwavering in our commitment to rebuilding U.S. industry and supporting American workers. China’s latest move only proves that our efforts are making an impact—and we will not back down.
America’s Generic Drug Crisis Demands Investment, Not Dependence
The United States is amid a dangerous drug shortage that endangers patients, undermines our health care system and exposes a deep vulnerability to national security. America’s overwhelming reliance on foreign manufacturers for generic drugs is at the center of it.
CPA Applauds President Trump’s “Liberation Day” Tariff Announcement as Essential Reset of Global Trade System
The Trump administration’s decision to impose a permanent 10% baseline tariff on imports from all countries, combined strategically with higher reciprocal tariffs on nations engaging in unfair trade practices, marks a crucial step forward in reindustrializing America and restoring economic strength and security.
Kenneth Rapoza: Happy Liberation Day, America
Break out the Grizzly cooler and fire up the Broilmaster—it’s Liberation Day. In President Trump’s words, April 2 marks the end of the US of A being “ripped off by virtually every country in the world.”
Wall Street Doesn’t Reflect the Real Economy
The stock market is not the economy, and it certainly isn’t a proxy for the health of U.S. manufacturing or working-class prosperity.
What the National Institutes of Health Does for the Economy and the Health of Our Citizens
The National Institutes of Health (NIH) is today the main source of new drugs in this country – indeed the world, because America leads in the field. It has a critical importance to America’s health. Less well known is its huge, positive, economic impact.
Mihir Torsekar: Getting It Right on Steel and Aluminum Tariffs
As the United States looks to compete in these advanced industries, it’s important to remember the two building blocks that undergird them: Steel and aluminum.
CPA Releases Recommendations for Bilateral Trade Actions
CPA’s new Trade Issues and Tariff Recommendation Tracker highlights specific tariff recommendations that will produce near-term wins.
